Effect of CVP and IOH on AKI and AKD
Completed
- Conditions
- Acute Kidney InjuryAcute Kidney Disease
- Interventions
- Other: Introperation hypotensionOther: Venous congestion
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2022-02-03
- Target Recruit Count
- 5127
- Registration Number
- NCT05222074
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2021-11-24
- Target Recruit Count
- 20
- Registration Number
- NCT05133349
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanjing Medical Univerity, Nanjing, Jiangsu, China
Effect of Physiological Ischemic Training on Patients With Atherosclerosis
Not Applicable
Recruiting
- Conditions
- Atherosclerosis
- Interventions
- Behavioral: exercise
- First Posted Date
- 2021-10-25
- Last Posted Date
- 2021-10-25
- Target Recruit Count
- 200
- Registration Number
- NCT05091762
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma
Not Applicable
Completed
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- Radiation: 68Ga-DOTA-NT-20.3
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-09-14
- Target Recruit Count
- 6
- Registration Number
- NCT05048810
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, China
Clinical Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients
- First Posted Date
- 2021-09-14
- Last Posted Date
- 2023-09-14
- Target Recruit Count
- 6
- Registration Number
- NCT05043675
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, China
Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2021-09-05
- Target Recruit Count
- 60
- Registration Number
- NCT05035849
- Locations
- 🇨🇳
Gu Gao, Nanjing, China
Correlation of Biomarkers With the Presence and Severity of Coronary Artery Disease
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Diagnostic Test: Medications or percutaneous coronary intervention
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2022-03-29
- Target Recruit Count
- 900
- Registration Number
- NCT05015270
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
Not Applicable
Recruiting
- Conditions
- Pulmonary Arterial Hypertension
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2022-09-28
- Target Recruit Count
- 420
- Registration Number
- NCT04972656
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
Enhanced Recovery After Surgery Protocols in Total Knee Arthroplasty Via Midvastus Approach
Not Applicable
Completed
- Conditions
- Knee OsteoarthritisERAS
- Interventions
- Procedure: ERAS protocols for TKA
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2021-05-10
- Target Recruit Count
- 69
- Registration Number
- NCT04873544
- Locations
- 🇨🇳
Nanjing first hospital, Nanjing, Jiangsu, China
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
Not Applicable
Recruiting
- Conditions
- Aortic Valve Disease
- Interventions
- Drug: Medical therapyDevice: Transcatheter Aortic Valve Implantation
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2024-03-21
- Target Recruit Count
- 210
- Registration Number
- NCT04864145
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath